Latest Headlines

  1. TORL Biotherapeutics Secures $96M For ADC Drug Development From UCLA Lab 10/7/2025

    TORL BioTherapeutics LLC (TORL), a clinical stage biotechnology company discovering and developing new antibody-based immunotherapies to improve and extend the lives of patients with cancer worldwide, today announced closing of a $96 million Series C financing. Additionally, updated results from the ongoing Phase 1 study of the Company's Claudin 6 (CLDN6) targeted antibody-drug conjugate (ADC) TORL-1-23 in patients with advanced cancer will be presented in poster sessions at the 2025 European Society of Medical Oncology Congress (ESMO 2025) in Berlin, Germany.

  2. RoosterBio And Secretome Therapeutics Announce Successful Completion Of Large Scale Bioreactor Production For Clinical Stage Cell Therapy Candidate STM-01 10/6/2025

    RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development services, and Secretome Therapeutics, a clinic-stage company developing novel therapies derived from neonatal cardiac progenitor cells (nCPC) today announced completion of commercial scale production of Secretome’s lead nCPC, STM-01.

  3. CDMO AbbVie Begins Construction On Biologics Manufacturing Facility Expansion In Massachusetts 10/2/2025

    AbbVie today announced the start of construction of a $70 million expansion at its AbbVie Bioresearch Center (ABC) in Worcester, Mass., which serves as a center of excellence for biologics research and development and manufacturing. This expansion is part of the company's previously announced commitment to invest more than $10 billion of capital in the U.S. to broadly support innovation and expand critical biologics manufacturing capabilities and capacity.

  4. Federal Equipment Company Announces Exclusive Sale Of Brand-New Aseptic Processing & Sterilization Equipment 10/2/2025

    Federal Equipment Company is pleased to announce the exclusive consignment of a suite of brand-new, never-used equipment designed for pharmaceutical and biotech aseptic processing. These state-of-the-art systems from leading manufacturers are now available for immediate purchase, offering buyers a unique opportunity to acquire high-performance technologies without the typical lead times of new builds.

  5. Bora Pharmaceuticals Introduces High-Potency Liquid Capsule Technology In Taiwan 9/30/2025

    Bora Pharmaceuticals Co., Ltd., a global leader in pharmaceutical manufacturing, has announced the addition of liquid-filled hard capsule (LFC) production capabilities at its Zhunan, Taiwan facility.

  6. Launch Of The Next Syringe Production Line 9/23/2025
  7. Abzena Enhances AbZelectPRO™ Cell Line Offering With New GS Knockout Platforms 9/16/2025
  8. FUJIFILM Biosciences Introduces BalanCD HEK293 Perfusion A Medium To Enable Gene Therapy Production 9/15/2025

    FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A.

  9. CAI Appoints Jamie Robertson As Vice President Of Mission Critical To Drive Innovation And Operational Excellence Across Global Infrastructure Projects 9/14/2025

    CAI, a global leader in operational readiness and excellence for high-stakes, regulated environments, is proud to announce the appointment of Jamie Robertson as Vice President of Mission Critical.

  10. Assets Of Sutro Biopharma To Be Auctioned – December 2025 9/11/2025

    Late-model lab R&D and manufacturing equipment surplus to future needs of Sutro biopharma: spray dryer, chromatography systems, Westfalia separators, HPLCs & more.